Persistent Circulating Tumor Cells At One Year After Oncologic Resection Of Pancreatic Cancer Predict Recurrence.

B Presenter: b Ding Ding MD, ScM | Johns Hopkins University School of Medicine B Background: b Circulating tumor cell (CTC) subtypes have been used as new biomarkers to predict early or late recurrence and response to treatment for pancreatic cancer. Both epithelial CTC (eCTC) and epithelial/mesenchymal CTC (mCTC) subtypes were used to predict recurrence from the CTC testing time within 9-15months after surgery. On multi-variable cox model including pathological covariates, neo-adjuvant, and adjuvant chemotherapy status, high eCTCs was a risk factor for recurrence since date of CTC testing(Hazard Ratio = 4.41; 95% CI [1.13, 17.23]; p=0.033). [Extracted from the article]